Case Report: Should IGF-1R targeted therapy be revisited in Ewing sarcoma? a report of long-term complete response and review of the literature. [PDF]
Stergiopoulos GM +7 more
europepmc +1 more source
AHNAK Contributes to Hepatocellular Carcinoma Growth by Interacting with IGF-1R. [PDF]
Li K +7 more
europepmc +1 more source
Developing cancer vaccine with carcinoembryonic antigen and IGF-1R as immunostimulants using immunoinformatics approach. [PDF]
Ezediuno LO +5 more
europepmc +1 more source
Linsitinib, an IGF-1R inhibitor, attenuates disease development and progression in a model of thyroid eye disease. [PDF]
Gulbins A +15 more
europepmc +1 more source
[Retracted] MicroRNA‑592 targets IGF‑1R to suppress cellular proliferation, migration and invasion in hepatocellular carcinoma. [PDF]
Wang W +6 more
europepmc +1 more source
CXCR4 mediates the effects of IGF-1R signaling in rodent bone homeostasis and fracture repair. [PDF]
Esposito A +4 more
europepmc +1 more source
Pitavastatin reduces intestinal fibrosis in chronic colitis and inhibits colon fibroblast activation by enhancing MMP-9 expression via the IGF-1/IGF-1R pathway. [PDF]
Zhang M, Lu H, Cheng J.
europepmc +1 more source
GIGYF1-disturbed IGF-1R recycling: a potential contributor to autism spectrum disorder pathogenesis? [PDF]
Xing M, Zhang Q, Song W.
europepmc +1 more source

